BioSpace News Archive

Elanco Animal Health Incorporated announced that it successfully priced its first lien senior secured credit facilities consisting of a term loan B facility in an aggregate principal amount of $4,275.0 million with a maturity of seven years and a revolving loan facility providing up to $750.0 million with a maturity of five years.

The U.S. Food and Drug Administration issued an emergency use authorization to enable emergency use of the Centers for Disease Control and Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel.

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, announced that it has commenced an underwritten public offering of 2,000,000 shares of its common stock.

Kezar Life Sciences, Inc. announced the closing of an underwritten public offering of 16,115,385 shares of its common stock, and to certain investors in lieu thereof, pre-funded warrants to purchase 2,884,615 shares of its common stock at an exercise price of $0.001 per share.

The 3M Board of Directors declared a dividend on the company’s common stock of $1.47 per share for the first quarter of 2020, an increase of 2 percent over the quarterly dividend paid in 2019.

Integra LifeSciences Holdings Corporation announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025.

MEDISCA Pharmaceutique Inc., a global leader of innovative products and services for the pharmaceutical compounding industry, is pleased to announce the issuance of United States Patent 10,420,705, covering an adapter for use in planetary mixers.